FDA Warns Drugmakers of Additional Cancer Risks Associated with CAR T-Cell Therapy
Pharmaceutical Executive...risksassociated with the treatment. The agency states that the letters ... Useartificial intelligence(AI) to focus on what matters. Jensen Huang …
Read the original at Pharmaceutical Executive ↗
- Topics
- HealthcareGovernment & Public Sector
- Mentions
- FDAJensen Huang
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”